Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

S2Medical AB (publ) announces conversion of BTU, first day of trading in warrants of series TO 1 and a correction regarding the number of shares

The rights issue of units that was announced on 15 March 2022 (the “Rights Issue”) in S2Medical AB (publ) (the "Company" or "S2Medical") has now been registered with the Swedish Companies Registration Office (Sw. Bolagsverket).   Last day for trading in BTU and first day for trading in warrants of series TO 1 Paid subscribed units (BTU) will be replaced by B shares and warrants of series TO 1. Trading with BTU ended yesterday (23 May 2022) and the stop date with Euroclear Sweden AB will occur on 25 May 2022, whereafter shares and warrants will be booked in each shareholder's VP

Atrium Ljungberg makes an acquisition in Hagastaden

Atrium Ljungberg has signed an agreement to acquire the Blästern 15 property in Hagastaden, Stockholm. The building comprises 21,300 m[2] and was acquired at an underlying property value of SEK 2,345 million. This acquisition strengthens Atrium Ljungberg’s position as one of the largest property owners and city developers in the growing district of Hagastaden.Blästern 15, which was designed by Ragnar Östberg, was built in the 1930s by the current owners AB Industricentralen, a privately-owned family company. It is a seven-storey building with a garage and currently has tenants primarily in

Bulletin from Balco Group’s Annual General Meeting 2022

Annual General Meeting for Balco Group AB was held on Tuesday May 24 2022, at Elite Stadshotellet, Kungsgatan 6 in Växjö.Press release Växjö May 24 2022 The Annual General Meeting approved the groups income statements and balance sheets and discharged the members of the board and CEO from liability for the financial year of 2021. The Annual General Meeting resolved on a dividend of SEK 2.00 per share, corresponding to a total of SEK 43,818,696, divided into two payments, SEK 1.00 per share in May 2022 and SEK 1.00 per share in November 2022. The Annual General Meeting approved

Minutes of the Annual General Meeting 2022 in DecideAct A/S and issuance of warrants to members of management and board of directors

Company Announcement no. 7-2022 DecideAct A/S (ACT) Tuesday 24 May 2022 at 15:00 CEST, DecideAct A/S (cvr.no. 36077735, the “Company”) held its annual general meeting as a fully electronic general meeting.Agenda 1. Election of chairman of the general meeting 2. Submission of the annual report for adoption 3. Decision on appropriation of profit or loss as recorded in the adopted annual report 4. Election of board of directors 5. Appointment of auditor 6. Proposals from the board of directors a. Authorisation to the board of directors re. capital increase without pre-

#22-179 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Notice of AGM

EnQuest PLC, 24 May 2022 EnQuest PLC Annual Report and Accounts and Notice of Meeting Following the release of EnQuest's 2021 full year audited results on 24 March 2022, and the simultaneous publication of the Company's 2021 Annual Report and Accounts ('ARA') on its website, the Company is pleased to announce that the ARA and the Notice of the 2022 Annual General Meeting ('AGM') have today been posted to shareholders. These documents are publicly available on the EnQuest PLC website (www.enquest.com), under the Investors section. In compliance with 9.6.1 of the Listing Rules, on 14

TIE Kinetix appoints new Partner Manager for Benelux, Nordics & UK

Breukelen, the Netherlands – May 24, 2022 at 6 PM CEST – TIE Kinetix , a leader in 100% supply chain digitalization, is pleased to announce that Mr. Roderick Madna has been appointed as the new Partner Manager for the Benelux, Nordics & UK.Roderick Madna has over 10 years of experience in service organizations, particularly in the Microsoft Cloud. Before joining TIE Kinetix, he held positions in partner and product management for several international cloud-oriented software companies in the Netherlands, including K3 Business Technologies and Prodware.   As the

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.05.2022

Fiskars Corporation   Stock Exchange Release 24.05.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 24.05.2022   Date 24.05.2022  Exchange transaction Buy  Share class FSKRS  Amount  8,700  Average price/share 18.9637 EURHighest price/share 19.1400 EURLowest price/share 18.7000 EURTotal price 164,984.19 EUR        The shares held by Fiskars Corporation on 24.05.2022:   FSKRS 663,430       On

Invitation to SAS’ Q2 2022 teleconference

SAS will publish the interim report for the second quarter of the fiscal year 2022 on Tuesday, 31[st] May 2022, at approximately 08.00 AM (CET). A teleconference and webcast for investors, analysts and media will be held at 10.00 AM (CET). Anko van der Werff, President & CEO and Erno Hildén, Executive Vice President & CFO will present and comment on the report. The presentation will be held in English via telephone or https://edge.media-server.com/mmc/p/9s7iqpeh No advance notification is necessary. Dial-in details for the conference call: DK: +45 354 455 77  FI: +358 981

First Quarter results 2022

Fornebu, 24th May 2022, Ocean Yield AS (“Ocean Yield” or the “Company”) announces results for the first quarter 2022.Highlights  · EBITDA for Q1 2022 was USD 41.1 million and EBITDA adjusted for finance lease effects was USD 68.4 million.  · Net profit for the period Q1 2022 was USD 22.1 million and adjusted net profit for Q1 2022 was USD 21.4 million.  · The sale of the vessels Navig8 Pride and Navig8 Providence was completed during the first quarter.  · Post quarter end, delivery of one newbuilding Suezmax tanker with long-term charter. · Continuing to expand the

Bulletin from the Annual General Meeting in Haldex AB

Haldex AB (publ) has held its annual general meeting on May 24, 2022. Among other things, the following resolutions were adopted. Adoption of the profit and loss account, the balance sheet, allocation of the company’s profit and discharge from liability The profit and loss account, the balance sheet and the consolidated profit and loss account and the consolidated balance sheet were adopted by the annual general meeting. The annual general meeting resolved that no dividend will be paid and that the accrued profits will be carried forward. All of the members of the board of

Calmark receives patent number for granted patent in the United States

Calmark Sweden AB (publ) has received announcement from the US Patent Office ("USPTO") regarding a granted patent covering the Calmark POC system and the method of detecting a biomarker in, for example, blood. The patent number is 11255864 and it is valid until April 6, 2039. Advance notice of this was press released on December 8, 2021.As previously announced, on December 8, 2021, the USPTO issued a so-called Notice of Allowance, which is a preliminary announcement that the patent will be granted. The number of the patent that has been finally granted is hereby announced.

Aquaporin A/S issues warrants under the existing incentive program and a new program

Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, VAT no.: DK28315694 Company announcementNo. 07/2022Inside information Copenhagen, Denmark, May 24, 2022– Aquaporin A/S (ticker:AQP.CO) (“Aquaporin” or the “Company”), an innovative water technology company dedicated to natural water treatment, today announced that the Board of Directors of Aquaporin has decided to grant warrants to Aquaporin’s Executive Management team and certain employees under Aquaporin’s existing long-term incentive program (the “2021 LTIP”) described in company announcement no. 13/2021 on

Volvo Cars raises EUR 500m for electrification through new green bond

Volvo Cars today successfully placed its second green bond to raise EUR 500m from a diverse set of global investors. The bond was oversubscribed three-times, despite challenging global market conditions. All proceeds are earmarked for funding and accelerating the company’s transformation towards becoming a fully electric carmaker by 2030 and becoming climate neutral and circular by 2040. Over two thirds of the proceeds will fund the research and development of electric powertrains for next generation pure electric Volvo cars as well as related new platform technology, while the rest

Supplement to press release on long-term financing released 24/5 2022

(Stockholm, Sweden, 24 May 2022) Inhalation Sciences AB has received a credit line from a consortium of lenders of up to SEK 10 million, giving the company increased scope to finance its operations and growth over the next 12-14 months.The company's chairman of the board, Daniel Spasic, is among the lenders through his American company S-Growth Capital LLC, with a loan of SEK 1 million. The company estimates that the credit line, together with self-generated funds, will be to sufficient to finance ISAB in line with its growth strategy for the coming 12-14 months. The term of the Loan

Beijer Electronics Group AB’s Annual Report 2021 now available in English-Language

BEIJER GROUP achieved notable successes, with high growth in 2021. The strong demand has been broad based, with good geographic diversity, covering all segments the Group addresses. Order intake was up by 40% to a new record level, passing a milestone of over 2 billion SEK. Sales increased by 13% and EBIT was nearly 70 million SEK. This is stated in BEIJER GROUP's Annual Report for 2021 in English-language, which is published today on the company's website www.beijergroup.com.BEIJER GROUP has focused on emerging stronger from the pandemic, and the economic challenges that dominated the

Bulletin from the annual general meeting in Truecaller AB (publ) on 24 May 2022

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Today, on 24 May 2022, the annual general meeting was held in Truecaller AB (publ). A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority. Resolution on adoption of accounts and distribution of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income statement and consolidated balance

Communiqué from the annual general meeting in NeoDynamics AB (publ)

The annual general meeting in NeoDynamics AB (publ) was held on 24 May 2022 at the company’s premises on Lejonvägen 14, Lidingö, whereby the shareholders primarily resolved on the following matters.   Annual report and result The annual report and the auditor's report for the financial year 2021 were presented and the income statement and balance sheet included in the annual report were adopted. It was resolved to not pay any dividends and that the company’s result shall be retained in the business.   Discharge from liability The annual general meeting resolved to grant

Inhalation Sciences presents comprehensive new strategy update

(Stockholm, Sweden, 24 May 2022) On 24 May Inhalation Sciences AB presented a major strategy update on its plans and goals for growth at RedEye in Stockholm Sweden. Watch the presentation here .Watch the full presentation, by CEO Manoush Masarrat and Chairman Daniel Spasic, here: https://www.redeye.se/video/event-presentation/843247/inhalation-sciences-strategy-update-by-manoush-masarrat-ceo-may-24-2022 (http://Watch the full presentation, by CEO Manoush Masarrat

Resolutions at Pharmacolog AB’s (publ) annual general meeting 2022

The shareholders of Pharmacolog in Uppsala AB (publ) held the Annual General Meeting on May 24, 2022 in Uppsala. (information below in Swedish only)Årsredovisning och resultatÅrsredovisning och revisionsberättelse framlades och resultat- och balansräkningen fastställdes. Det beslutades att disponera bolagets resultat i enlighet med styrelsens förslag.  AnsvarsfrihetStämman beslutade att lämna ansvarsfrihet åt styrelseledamöterna och verkställande direktören. ArvodenStyrelsearvodet fastställdes med 150 000 kronor till ordföranden och 100 000 kronor vardera till övriga ledamöter.

Tokmanni to open its completely remodelled Porttipuisto store in Vantaa – Largest Tokmanni in the Helsinki metropolitan area now has a Miny lifestyle brand shop-in-shop department

Tokmanni     Press release     24 May 2022 at 4:40 p.m. Tokmanni’s largest store in the Helsinki metropolitan area serves its customers at Porttipuisto in Vantaa. Comprehensive product selections and a pleasant shopping experience have been focused on at the newly remodelled store, which measures almost 6,150 square metres. Tokmanni will celebrate the opening of its completely remodelled store at Porttipuisto  in Vantaa on Wednesday 25 May 2022 at 8.00 am with special offers 

ASETEK - Notice of Extraordinary General Meeting June 15, 2022

The Board of Directors of Asetek A/S hereby gives notice of an extraordinary general meeting to be held on June 15, 2022 in Aalborg, Denmark with the purpose of electing an additional board member.The notice convening the general meeting, the agenda, and the full text of the proposal can be downloaded from https://https://ir.asetek.com/governance/general-meetings/.On the day of the notice of the general meeting there are 27,000,134 shares and 27,000,134 voting rights in Asetek A/S.For further information, please contact:Peter Dam MadsenChief Financial OfficerMobile: +45 2080

Alzinova initiates development of a stable cell line to prepare the monoclonal antibody ALZ-201 for Alzheimer’s clinical trials

Alzinova AB (publ) (“Alzinova” or the “Company”) today announces the initiation of the next step in the preclinical development of its oligomer-specific monoclonal antibody, ALZ-201. The Company is developing ALZ-201 as a second product in its portfolio of Alzheimer’s treatments, along with its vaccine candidate, ALZ-101, which is currently in Phase 1b clinical development.The Company has now initiated the development of a stable cell line to produce high and consistent levels of ALZ-201. In this process, the goal is to isolate single, viable, and high-producing cell clones to ensure

There are no items matching the current filter
There are no more items matching the current filter
Back to top